Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Drs. Ben Solomon, Leora Horn, & Jack West consider whether immunotherapy might prove to be more problematic when given to a broader population of older and frail patients with advanced lung cancer.
Following the excellent podcast by Dr. Rogerio Lilenbaum, lung cancer expert and now Chair of Cleveland Clinic Florida in Weston, on Considerations and Challenges of Treating Elderly Patients with Lung Cancer, he fielded questions from me and the folks in the live audience who attended. Here's that question and answer session, provided in audio and with the associated transcript. There isn't really any video/figures for this one.
[powerpress]
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.